EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial sensitive probe with aggregation‐induced emission characteristics for early brain diagnosis of Parkinson's disease

Liwen Huang, Yutong Zhou, Di Jiao, Jing Ren, Yilin Qi, Heping Wang, Yang Shi, Dan Ding, Xue Xue

Aggregate · 2024-02 · 5 (1)

DOI: 10.1002/agt2.403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aggregate, online erschienen am 08.08.2023. Verfasst von Liwen Huang und 8 weiteren Autor:innen. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Biochemical Engineering.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The early diagnosis of Parkinson's disease (PD) provides opportunities for early intervention to slow the progression of neurological degeneration in patients, particularly as the aging population increases in our society. Among a series of pathological features of PD, mitochondria abnormalities have been identified as central event that occurs at the early stage of PD. However, the method for detecting mitochondrial abnormalities‐associated early PD has not been fully developed. We herein report a specifically mitochondrial targeting probe (named TPA‐BT‐SCP) that is able to characterize mitochondria abnormalities for early diagnosis of PD and monitor PD neurodegenerative progress. The probe is an aggregation‐induced emission (AIE) probe with a strong positive charge, a 3D distorted molecular structure, and a separated HOMO‐LUMO distribution, designed with unique molecular design guidelines. Our research demonstrated that TPA‐BT‐SCP could emit stable and strong fluorescence, and rapidly accumulate in mitochondria due to the negative charge. After intranasal administration of 1‐methy‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced PD mice, TPA‐BT‐SCP successfully bypassed the blood−brain barrier to light up the brain, allowing the grading of PD severity based on its high sensitivity. Taken together, this work develops a novel AIE probe that exhibits dramatically high sensitivity to mitochondrial changes and enables noninvasive diagnosis of early PD in the brain.

Förderung

  • National Natural Science Foundation of China
  • State Key Laboratory of Biochemical Engineering

Zitieren

APA

Huang, L., Zhou, Y., Jiao, D., Ren, J., Qi, Y., Wang, H., Shi, Y., Ding, D., & Xue, X. (2024). Mitochondrial sensitive probe with aggregation‐induced emission characteristics for early brain diagnosis of Parkinson's disease. Aggregate, 5(1). https://doi.org/10.1002/agt2.403

Vancouver

Huang L, Zhou Y, Jiao D, Ren J, Qi Y, Wang H, et al. Mitochondrial sensitive probe with aggregation‐induced emission characteristics for early brain diagnosis of Parkinson's disease. Aggregate. 2024;5(1). doi:10.1002/agt2.403

BibTeX
@article{Huang2024,
  author = {Huang, Liwen and Zhou, Yutong and Jiao, Di and Ren, Jing and Qi, Yilin and Wang, Heping and Shi, Yang and Ding, Dan and Xue, Xue},
  title = {Mitochondrial sensitive probe with aggregation‐induced emission characteristics for early brain diagnosis of Parkinson's disease},
  journal = {Aggregate},
  year = {2024},
  volume = {5},
  number = {1},
  doi = {10.1002/agt2.403}
}
Kostenlos starten →